Hepatitis B in the Greater San Francisco Bay Area: An Integrated Response to a Local Epidemic
Author Information
Author(s): Robert G. Gish, Stewart Cooper
Primary Institution: California Pacific Medical Center
Hypothesis
There is an urgent need for integrated programmes that identify, follow, and treat people with existing chronic hepatitis B (CHB) while vaccinating the susceptible.
Conclusion
The San Francisco programme successfully screened over 3000 at-risk individuals and demonstrated a model for improving hepatitis B management in underserved populations.
Supporting Evidence
- Chronic hepatitis B affects approximately 2 million people in the US, with many remaining undiagnosed.
- Screening programs in high-density Asian and Pacific Islander areas have reported a 10-15% prevalence of chronic hepatitis B.
- Community awareness and healthcare provider knowledge about hepatitis B remain low despite its high prevalence.
Takeaway
This study shows that many people in San Francisco have hepatitis B without knowing it, and a special program helped find and treat them.
Methodology
The study involved screening over 3000 at-risk individuals in various community settings and providing follow-up care and vaccination.
Potential Biases
Potential bias due to underrepresentation of certain populations in screening efforts.
Limitations
The study faced challenges in follow-up and ensuring treatment for uninsured individuals.
Participant Demographics
The majority of participants were Asian and Pacific Islanders, with a significant number being foreign-born.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website